ELEVATED CARDIAC SPECIFIC TROPONIN CONCENTRATION IN THE ABSENCE OF MYOCARDIAL INFARCTION. PART 1


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Elevated cardiac troponin concentrations are observed in various clinical situations without acute coronary syndrome, and therefore physicians often find it difficult to interpret positive troponin levels. The emergence of high-sensitivity analyses has led to the accelerated diagnosis of myocardial infarction - rapid (1- and 3-hour) diagnostic algorithms; however, additional problems have appeared due to low specificity. The review describes the reasons for the elevated concentration of cardiac troponins without myocardial infarction. The mechanisms for elevation of cardiac troponins and their diagnostic value in various nosological entities are discussed. Part 1 of the paper considers the mechanisms for elevation of troponins and their diagnostic value in diseases having the clinical symptoms similar to those of myocardial infarction, which frequently causes diagnostic errors. These include pulmonary embolism, myocarditis, and Takotsubo syndrome.

全文:

受限制的访问

作者简介

A. Chaulin

Samara Regional Clinical Cardiology Dispensary; Samara State Medical University

Email: alekseymichailovich22976@gmail.com
Samara

L. Karslyan

Samara Regional Clinical Cardiology Dispensary; Samara State Medical University

Candidate of Medical Sciences Samara

A. Aleksandrov

OOO «INVITRO-Samara»

Samara

I. Duplyakov

Samara Regional Clinical Cardiology Dispensary; Samara State Medical University

Professor, MD Samara

参考

  1. Fanaroff A., Rymer J., Goldstein S. et al. Does This Patient With Chest Pain Have Acute Coronary Syndrome?: The Rational Clinical Examination Systematic Review // JAMA. - 2015; 314 (18): 1955-65. doi: 10.1001/jama.2015.12735.
  2. Roffi M., Patrono C., Collet J. et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardio-logy (ESC) // Eur. Heart J. - 2016; 37 (3): 267-315. https://doi.org/10.1093/ eurheartj/ehv320.
  3. Ibanez B., James S., Agewall S. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) // Eur. Heart J. - 2018; 39 (2): 119-77. doi: 10.1093/eurheartj/ehx393.
  4. Thygesen K., Alpert J., Jaffe A. et al. Fourth universal definition of myocardial infarction (2018) // Eur. Heart. J. - 2019; 40 (3): 237-69. doi: 10.1093/eurheartj/ ehy462.
  5. Дылева Ю.А., Груздева О.В, Учасова Е.Г. и др. Стимулирующий фактор роста ST2 в кардиологии: настоящее и перспективы // Лечащий врач. - 2017; 11: 65-71 URL: https://www.lvrach.ru/2017/11/15436850/
  6. Giannitsis E., Katus H. Pros and cons of high-sensitivity assays for cardiac troponin // Nat. Rev. Cardiol. - 2012; 9 (11): 616-8. doi: 10.1038/nrcardio.2012.142.
  7. Nallet O., Arbaoui S., Grenier A. et al. Troponin in emergency department: an overused test for patients screening without clinical suspicion of acute coronary syndrome? // Arch. Cardiovasc. Dis. Suppl. - 2011; 3 (1): 109. https://doi. org/10.1016/S1878-6480(11)70326-3.
  8. Narula J., Haider N., Virmani R. et al. Apoptosis in myocytes in end-stage heart failure //N. Engl. J. Med. -1996;335 (16): 1182-9. doi: 10.1056/NEJM199610173351603.
  9. Bergmann O., Bhardwaj R., Bernard S. et al. Evidence for cardiomyocyte renewal in humans // Science. - 2009; 324 (5923): 98-102. DOI: 10.1126/ science.1164680.
  10. Вельков В.В. Революция в кардиологии; высокочувствительное измерение кардиальных тропонинов: «тропонин-отрицательных» больше нет // Клинико-лабораторный консилиум. - 2011; 4 (40): 24-43 URL: https://elibrary.ru/item.asp?id=17283055
  11. McDonough J., Arrell D., Van Eyk J. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury // Circ. Res. - 1999; 84 (1): 9-20. doi: 10.1161/01.res.84.1.9.
  12. Schwartz P., Piper H., Spahr R. et al. Ultrastructure of cultured adult myocardial cells during anoxia and reoxygenation // Am. J. Pathol. - 1984; 115 (3): 349-61.
  13. White H. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? // J. Am. Coll. Cardiol. - 2011; 57 (24): 2406-8. doi: 10.1016/j.jacc.2011.01.029.
  14. Li D., Keffer J., Corry K. et al. Nonspecific elevation of troponin T in patients with chronic renal failure // Clin. Biochem. - 1995; 28 (4): 474-7.
  15. Agewall S., Giannitsis E., Jernberg T. et al. Troponin elevation in coronary vs. non-coronary disease // Eur. Heart J. - 2011; 32 (4): 404-11. DOI: 10.1093/ eurheartj/ehq456.
  16. Newby L., Jesse R., Babb J. et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American college of cardiology foundation task force on Clinical expert consensus documents // J. Am. Coll. Cardiol. - 2012; 60 (23): 2427-63. doi: 10.1016/j.jacc.2012.08.969.
  17. Kontos M., Jesse R., Tatum J. et al. Coronary angiographic findings in patients with cocaine-associated chest pain // J. Emerg. Med. - 2003; 24 (1): 9-13. https://doi.org/10.1016/S0736-4679(02)00660-1.
  18. Konstantinides S., Torbicki A., Agnelli G. et al. Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism // Eur. Heart J. - 2014; 35 (43): 3033-80.
  19. Разин В.А., Сапожников А.Н., Мазурова О.В. и др. Тромбоэмболия легочной артерии: особенности диагностики и лечения в условиях отделения острого коронарного синдрома // Ульяновский медико-биологический журнал. -2012; 1: 13-6
  20. Giannitsis E., Muller-Bardorff M., Kurowski V. et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism // Circulation. - 2000; 102 (2): 211-7. https://doi.org/10.1161/01.cir.102.2.211.
  21. Muller-Bardorff M., Weidtmann B., Giannitsis E. et al. Release kinetics of cardiac troponin T in survivors of confirmed severe pulmonary embolism // Clin. Chem. - 2002; 48: 673-5.
  22. Jerjes-Sanchez C., Ramirez-Rivera A., de Lourdes Garcia M. et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial // J. Thromb. Thrombolysis. - 1995; 2 (3): 227-9.
  23. Meyer T., Binder L., Hruska N., et al. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction // J. Am. Coll. Cardiol. - 2000; 36 (5): 1632-6. doi: 10.1016/s0735-1097(00)00905-0.
  24. Cotungo M., Orgaz-Molina J., Rosa-Salazar V. et al. Right ventricular dysfunction in acute pulmonary embolism: NT-proBNP vs. troponin T // Med. Clin. (Barc.). - 2017; 148 (8): 339-44. doi: 10.1016/j.medcli.2016.11.023.
  25. Kim J., Kim K., Cho J. et al. D-dimer/troponin ratio in the differential diagnosis of acute pulmonary embolism from non-ST elevation myocardial infarction // Korean J. Intern. Med. - 2019. URL: https://doi.org/10.3904/ kjim.2018.153
  26. Lauer B., Niederau C., Kuhl U. et al. Cardiac troponin T in patients with clinically suspected myocarditis // J. Am. Coll. Cardiol - 1997; 30 (5): 1354-9. doi: 10.1016/s0735-1097(97)00317-3.
  27. Mansencal N., Auvert B., N’Guetta R. et al. Prospective assessment of incidence of Tako-Tsubo cardiomyopathy in a very large urban agglomeration // Int. J. Cardiol. - 2013; 168 (3): 2791-5. doi: 10.1016/j.ijcard.2013.03.124.
  28. Soongswang J., Durongpisitkul K., Ratanarapee S. et al. Cardiac troponin T: a marker in the diagnosis of clinically suspected acute myocarditis and chronic dilated cardiomyopathy in children // Pediatr. Cardiol. - 2002; 23 (5): 531-5.
  29. Soongswang J., Durongpisitkul K., Nana A. et al. Cardiac troponin T: a marker in the diagnosis of acute myocarditis in children // Pediatr. Cardiol. - 2005; 26 (1): 45-9. doi: 10.1007/s00246-004-0677-6.
  30. Ukena C., Kindermann M., Mahfoud F. et al. Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis // Clin. Res. Cardiol. - 2014; 103 (9): 743-51. doi: 10.1007/s00392-014-0709-z/
  31. Chang Y., Hsiao H., Hsia S. et al. Analysis of clinical parameters and echocardiography as predictors of fatal pediatric myocarditis // PLoS One. - 2019; 14 (3): e0214087. doi: 10.1371/journal.pone.0214087.
  32. Dancea A. Myocarditis in infants and children: A review for the paediatrician // Paediatrics & Child Health. - 2001; 6 (8): 543-5. doi: 10.1093/pch/6.8.543.
  33. Abrar S., Ansari M., Mittal M. et al. Predictors of Mortality in Paediatric Myocarditis // J. Clin. Diagn. Res. - 2016; 10 (6): SC12-6. DOI: 10.7860/ JCDR/2016/19856.7967.
  34. Prasad A., Lerman A., Rihal C. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction // Am. Heart. J. -2008; 155 (3): 408-17. doi: 10.1016/j.ahj.2007.11.008.
  35. Yayehd K., N’da N., Belle L. et al. Management of Takotsubo cardiomyopathy in non-academic hospitals in France: The Observational French SyndromEs of TakoTsubo (OFSETT) study // Arch. Cardiovasc. Dis. - 2016; 109 (1): 4-12.
  36. Ahmed K., Madhavan M., Prasad A. Brain natriuretic peptide in apical ballooning syndrome (Takotsubo/stress cardiomyopathy): comparison with acute myocardial infarction // Coron. Artery Dis. - 2012; 23 (4): 259-64. DOI: 10.1097/ MCA.0b013e3283526a57.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2020